Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

MedSource acquires Datatrial data services division

Houston-based MedSource expanded its clinical development repertoire, acquiring the data services division of biometrics and technology company Datatrial in early 2017. The deal both strengthens MedSource’s position as a full-service CRO and paves the way for a greater presence within the European market, accelerating MedSource’s growth trajectory as a result. For the past three years, […]

The post MedSource acquires Datatrial data services division appeared first on CenterWatch News Online.

Powered by WPeMatico

News

Cannabis intoxication may be stopped with anti-obesity drug

Intoxication with so-called legal highs may be fatal. But new research may have found the antidote in a slimming drug that blocks cannabinoid receptors. Powered by WPeMatico

more >

Heart failure could be treated using umbilical cord stem cells

In the first study of its kind, researchers find that stem cells derived from the umbilical cord can be used to treat heart failure. Powered by WPeMatico

more >

Poliovirus kills off cancer cells, stops tumor regrowth

A modified poliovirus appears to trigger the body’s anti-tumor immunity. The new study showed promising results in human breast cancer cells and mice. Powered by WPeMatico

more >

Drug resistance: WHO report ‘serious lack of new antibiotics’

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance. Powered by WPeMatico

more >

Alexion restructures, cuts workforce 20%

Alexion Pharmaceuticals announced an operational plan to re-align the global organization with its refocused corporate strategy. The plan is expected to deliver approximately $270 million in GAAP and approximately $250 million in non-GAAP pre-tax savings annually by 2019. The restructuring will reduce the company’s global workforce by approximately 20%. The resulting savings will allow Alexion […]

more >

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of institutional and private investors. As part of the transaction, ProQR has granted an exclusive license to Amylon to develop therapeutics for beta amyloid related disorders. Amylon […]

more >